Seres Therapeutics Inc.

NASDAQ: MCRB · Real-Time Price · USD
16.70
-0.16 (-0.95%)
At close: Aug 15, 2025, 3:59 PM
16.08
-3.74%
After-hours: Aug 15, 2025, 07:58 PM EDT

Seres Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
136K -113.72M -250.16M -65.58M
Depreciation & Amortization
5.47M 6.24M 6.63M 5.95M
Stock-Based Compensation
20.97M 34.1M 25.48M 20.22M
Other Working Capital
-26.71M -9.08M -20.59M -4.36M
Other Non-Cash Items
-109.67M 15M 7.62M 2.04M
Deferred Income Tax
n/a n/a n/a 2.53M
Change in Working Capital
-65.51M -58.98M -18.39M 41.53M
Operating Cash Flow
-148.61M -117.35M -228.82M 6.69M
Capital Expenditures
-380K -7.97M -9.82M -9.57M
Cash Acquisitions
n/a n/a -92.25M -73.65M
Purchase of Investments
n/a -4.43M -48.22M -95.97M
Sales Maturities Of Investments
1.4M 22.98M 140.47M 169.63M
Other Investing Acitivies
142.67M n/a 92.25M 73.65M
Investing Cash Flow
142.29M 10.58M 82.43M 64.09M
Debt Repayment
-127.91M 50.52M 25.7M -948K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
13.52M 3.03M 2.73M 2.13M
Financial Cash Flow
-90.37M 71.7M 129.6M 1.18M
Net Cash Flow
-96.69M -35.06M -16.79M 71.95M
Free Cash Flow
-148.99M -125.33M -238.64M -2.88M